Milestone Scientific Enhances Epidural System with Expert Collaboration
Milestone Scientific Rolls Out CompuFlo Epidural System
In a significant development for pain management technology, Milestone Scientific Inc. (NYSE: MLSS), a pioneer in computerized drug delivery instruments, has announced the commercial rollout of its groundbreaking CompuFlo Epidural System at Hudson Specialty Care. This initiative is spearheaded by the distinguished pain management physician, Dr. Elbaz. The collaboration emphasizes Milestone’s ongoing commitment to enhancing patient comfort through innovative solutions.
Growing Access to Advanced Pain Management Solutions
Milestone's decision to expand its presence at Hudson Specialty Care is greatly influenced by the recent adjustments in Medicare pricing strategies. With the updated Medicare Part B Physician payment rates, which include support for CompuFlo under the AMA's technology-specific Category III CPT code CPT0777T, patient access to this state-of-the-art system is greatly facilitated. Dr. Elbaz and his team embrace this technology to deliver more precise and effective pain management services.
Expert Insights: Dr. Elbaz on CompuFlo's Advantages
Dr. Elbaz, recognized for his expertise in spinal health, expressed his enthusiasm about the partnership. He stated the significance of incorporating advanced technologies like the CompuFlo Epidural System, which utilizes real-time pressure sensing. This level of precision is paramount in ensuring better patient outcomes and enhancing overall satisfaction during interventional procedures.
Commitment to Patient-Centric Care
Dr. Elbaz remarked how the integration of the CompuFlo system aligns perfectly with Hudson Specialty Care's mission of providing top-tier care. The real-time data provided by the system not only boosts confidence during epidural procedures but also minimizes risks associated with conventional techniques.
Participation in Pain Medicine Congress 2024
Milestone Scientific has announced its participation in the upcoming New York and New Jersey Pain Medicine Congress 2024. This event, organized by leading societies in interventional pain management, offers an excellent platform for showcasing innovations like the CompuFlo Epidural System. The congress aims to educate healthcare professionals about best practices and recent advancements in pain management and treatment methodologies.
Showcasing Innovation in Pain Management
CEO Arjan Haverhals highlighted the significance of exhibiting at such reputable events. He noted that opportunities like these allow Milestone Scientific to demonstrate the efficacy and safety of their epidural solutions to a select audience of top pain management professionals in the New York and New Jersey regions.
Enhancing Safety and Efficiency in Epidural Procedures
The CompuFlo Epidural System is built on proprietary technology designed to aid anesthesiologists in accurately identifying the epidural space, thereby minimizing the likelihood of erroneous placements, which can lead to complications. This innovative solution promises to elevate the standard of care and improve recovery experiences for patients, emphasizing efficiency without compromising safety.
About Milestone Scientific Inc.
Milestone Scientific Inc. is at the forefront of innovation in the medical device sector, particularly noted for its focus on the development of injection technologies that enhance precision and patient comfort. With the introduction of the DPS Dynamic Pressure Sensing Technology, Milestone is setting new benchmarks in medical and dental practices, creating devices that ensure safer and more effective injections across various applications.
Frequently Asked Questions
What is the CompuFlo Epidural System?
The CompuFlo Epidural System is a technological innovation designed to enhance the precision of epidural injections through real-time pressure sensing.
Who is Dr. Elbaz?
Dr. Elbaz is a renowned pain management physician specializing in spinal health and is currently leading the implementation of the CompuFlo system at Hudson Specialty Care.
What are the benefits of the CompuFlo system?
The system provides increased accuracy during procedures, reduces the risk of false placements, and ultimately improves patient outcomes.
Where will Milestone be demonstrating its technology?
Milestone Scientific will showcase its CompuFlo Epidural System at the New York and New Jersey Pain Medicine Congress 2024.
How does the new Medicare pricing impact access to CompuFlo?
The updated Medicare Part B payment rates enhance accessibility, making it easier for practices to adopt the CompuFlo Epidural System in patient care.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
